Palliative treatment of rectal carcinoma using a urologic resectoscope - 06/05/08
Mohamed Ziani* [1],
Jean-Jacques Tuech* [1],
Denis Chautard [1],
Nicolas Regenet [1],
Patrick Pessaux [1],
Serge Randriamananjo [1],
Jean-Pierre Arnaud [1]
Voir les affiliations
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Objective |
The aim of this study was to report our experience with endoscopic transanal resection (ETAR) using a urologic resectoscope for palliative treatment of rectal carcinoma.
Methods |
Outcome in patients who underwent ETAR with a urologic resectoscope between October 1992 and March 1999 are reported.
Results |
The 60 ETAR procedures were performed in 37 patients (19 men and 18 women, median age 82 years). Morbidity was 10% (6 patients) and mortality was 2.7% (1 patient). Median hospital stay for the procedure was 5 days. Symptom control was achieved in 86% of the patients (40% partial control, 46% complete control). Colostomy was performed in 8 patients 7 months after ETAR. At study end, 4 patients were alive. Median survival was 14 months (range 0-62). The 1-, 2-, and 5-year survival rates were 54, 32 and 5%, respectively.
Conclusion |
ETAR is a simple, minimally invasive and economical method for palliative treatment of patients with rectal carcinoma. ETAR is a useful addition to the surgeon's armamentarium.
Keywords:
Rectal carcinoma
,
Palliative treatment
,
Endoscopy
,
Urologic resectoscope
Plan
© 2001 Elsevier Masson SAS. Tous droits réservés.
Vol 25 - N° 11
P. 957-961 - novembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.